David Smith
Vermögen: 2 Mio $ am 30.09.2026
Vermögen: 2 Mio $ am 30.09.2026
Dr. David A. Smith is a Non-Executive Chairman at TheraCryf Plc, an Independent Non-Executive Director at Thalia Therapeutics Plc and a Non-Executive Chairman at SPARTA Biodiscovery Ltd. He is on the Board of Directors at Thalia Therapeutics Plc and Nextmune Laboratories Ltd. Dr. Smith was previously employed as a Chief Executive Officer & Executive Director by Avacta Group Plc, a Chief Executive Officer & Director by Avacta Life Sciences Ltd., and a Director-Institute of Molecular Biophysics by University of Leeds.
He also served on the board at TheraGenetics Ltd. He received his undergraduate degree from The University of Manchester and a doctorate degree from The University of Manchester.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
AVACTA GROUP PLC 0,33 % | 04.06.2025 | 1 565 100 ( 0,33 % ) | 1 Mio $ | 30.09.2026 |
THERACRYF PLC 1,33 % | 09.09.2026 | 36 212 888 ( 1,33 % ) | 86 549 $ | 30.09.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| THALIA THERAPEUTICS PLC | Direktor/Vorstandsmitglied | 08.01.2025 |
| THERACRYF PLC | Vorsitzender | 19.02.2025 |
Sparta Biodiscovery Ltd.
Sparta Biodiscovery Ltd. Medical SpecialtiesHealth Technology Manufactures instruments for chemical analysis and pharmaceutical research | Vorsitzender | - |
Avacta Animal Health Ltd.
Avacta Animal Health Ltd. Miscellaneous Commercial ServicesCommercial Services Provides veterinary allergy diagnostic solutions through laboratories | Direktor/Vorstandsmitglied | 06.02.2009 |
| Unternehmen | Position | Ende |
|---|---|---|
| AVACTA GROUP PLC | Gründer | 01.05.2024 |
Avacta Life Sciences Ltd.
Avacta Life Sciences Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Vorstandsvorsitzender | - |
TheraGenetics Ltd.
TheraGenetics Ltd. Pharmaceuticals: MajorHealth Technology Manufactures brachytherapy seeds for prostate and localized cancers | Direktor/Vorstandsmitglied | - |
University of Leeds
University of Leeds Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 9 |
|---|---|
Evgen Pharma Plc
Evgen Pharma Plc Medical/Nursing ServicesHealth Services Engages in the development of pharmaceutical products and focus on cancer & neurological disease | Health Services |
The University of Manchester
The University of Manchester Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Leeds
University of Leeds Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Avacta Group Plc
Avacta Group Plc Miscellaneous Commercial ServicesCommercial Services Engages in the business of healthcare technology and consumables | Commercial Services |
TheraGenetics Ltd.
TheraGenetics Ltd. Pharmaceuticals: MajorHealth Technology Manufactures brachytherapy seeds for prostate and localized cancers | Health Technology |
Avacta Animal Health Ltd.
Avacta Animal Health Ltd. Miscellaneous Commercial ServicesCommercial Services Provides veterinary allergy diagnostic solutions through laboratories | Commercial Services |
Avacta Life Sciences Ltd.
Avacta Life Sciences Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
N4 Pharma Plc
N4 Pharma Plc BiotechnologyHealth Technology Provides specialist pharmaceutical services that reformulates existing drugs and vaccines to improve their performance | Health Technology |
Sparta Biodiscovery Ltd.
Sparta Biodiscovery Ltd. Medical SpecialtiesHealth Technology Manufactures instruments for chemical analysis and pharmaceutical research | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen